1. P01.15.A Longitudinal assessment of neurocognition and quality of life in low-grade glioma patients receiving first-line Temozolomide. (5th September 2022) Authors: Darlix, A; Fabbro, M; Monnier, M; Castan, F; Coutant, L; Denis, E; Carriere, M; Menjot de Champfleur, N; Rigau, V; Duffau, H; Guerdoux, E Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗